BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
ERBB2
,
G-protein-coupled receptor binding
,
Influenza
,
Kidney
,
Hematopoietic cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
VL30
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Injury of eye region
Disorder of cornea
Ischemia
Disease caused by parasite
Multiple organ dysfunction syndrome
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Deferoxamine
beta-cyclodextrin-benzaldehyde
aluminum sulfate
Benzodiazepinones
Lif protein, mouse
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
RIF1
IRF4
CRYAB
PDE10A
CLCN1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Tinzaparin inhibits VL30 retrotransposition induced by oxidative stress and/or VEGF in HC11 mouse pr…
Genomic analysis of mouse VL30 retrotransposons.
VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mou…
Arsenic induces VL30 retrotransposition: the involvement of oxidative stress and heat-shock protein …
Trim24-repressed VL30 retrotransposons regulate gene expression by producing noncoding RNA.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Power Training on Muscle Quality and Functional Capacity in Women Aged 65-75.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ